Regeneron signs over $3 billion deal with contract drugmaker to boost US manufacturing

  • Regeneron Pharmaceuticals said on Tuesday it had entered into a deal valued at more than $3 billion with contract drug developer Fujifilm Diosynth to expand its U.S. manufacturing capacity.